Table 2 Adjusted prevalence and trend of pre-hypertension and hypertension based on JNC-VII guideline in adolescents aged 15–19: SuRFNCD 2007–2011

18.33 (15.91–20.75)

17.71 (15.36–20.06)

18.04 (15.55–20.52)

20.06 (16.41–23.71)

0.540

8.02 (6.31–9.72)

6.98 (5.49–8.46)

6.56 (5.04–8.08)

9.06 (6.44–11.69)

0.510

22.25 (19.37–25.13)

21.63 (18.76–24.50)

22.04 (19.15–24.92)

24.13 (19.74–28.52)

0.279

10.35 (8.19–12.52)

9.07 (6.99–11.14)

8.53 (6.57–10.48)

11.60 (8.29–14.91)

0.425

28.96 (26.39–31.54)

27.28 (24.87–29.69)

31.61 (28.83–34.39)

29.24 (24.83–33.66)

0.937

12.76 (10.82–14.71)

10.81 (9.12–12.50)

12.27 (10.26–14.28)

15.04 (11.26–18.82)

0.099

31.58 (28.36–34.80)

26.65 (26.59–32.71)

34.34 (31.10–37.58)

32.05 (27.03–37.07)

0.182

9.95 (7.89–12.01)

8.39 (6.59–10.20)

9.53 (7.61–11.44)

11.79 (8.69–14.89)

0.502